ask="30.25"
ask_size="100"
average_daily_volume="889700"
bid="30.00"
bid_size="1500"
book_value="5.75"
change="+1.90"
change_from_200_day_moving_average="11.09"
change_from_50_day_moving_average="10.14"
change_from_52_week_high="-0.15"
change_From_52_week_low="17.51"
change_in_percent="+6.82%"
close="29.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.25"
ebitda="-70.16M"
eps_estimate_current_year="-2.39"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.79"
ex_dividend_date="N/A"
float_shares="24615000"
high="29.90"
high_52_weeks="29.90"
last_trade_date="3/1/2017"
last_trade_price="29.75"
last_trade_size="31318"
last_trade_time="4:00pm"
low="27.20"
low_52_weeks="12.24"
market_capitalization="1.11B"
moving_average_200_day="18.66"
moving_average_50_day="19.61"
name="Global Blood Therapeutics
Inc."
notes="N/A"
one_year_target_price="50.83"
open="27.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+59.40%"
percent_change_from_50_day_moving_average="+51.69%"
percent_change_from_52_week_high="-0.50%"
percent_change_from_52_week_low="+143.06%"
previous_close="27.85"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.84"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37316000"
short_ratio="9.70"
stock_exchange="NMS"
symbol="GBT"
volume="1767038"
weeks_range_52="12.24 - 29.90"
